GMPs and Creating a Quality Culture

GMPs and Creating a Quality Culture

07/15/2020, 1:15 PM - 3:00 PM

Innovation Stage, Booth 1281, Exhibit Hall
Recent FDA warning letters—often received years after inspectors first noticed the problems in 483s— have identified deficiencies in many pharma company quality systems, as well as failures to understand the root causes of recurring problems. In this session, experts will examine typical gaps in performance and how to prevent them from resulting in costly quality and compliance problems.


  • Tim Croft


    Vice President, Client Solutions

    NSF International, Health Sciences

  • Agnes Shanley


    Senior Editor

    Pharmaceutical Technology and BioPharm International

Type of Session

  1. Type of Session


  1. Track
    Keynote Series

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.